BWAY
Brainsway Ltd
NASDAQ: BWAY · HEALTHCARE · MEDICAL DEVICES
$16.74
-2.66% today
Updated 2026-06-05
Market cap
$572.12M
P/E ratio
64.86
P/S ratio
10.18x
EPS (TTM)
$0.22
Dividend yield
—
52W range
$5 – $17
Volume
0.1M
Brainsway Ltd (BWAY) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$16.74
12-Month target
$6.75
2030 Target
$9.55
Intrinsic (DCF)
—
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2027 (E) | 2028 (E) | 2029 (E) | 2030 (E) |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.0B | $0.0B | $0.0B | $0.0B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B |
| EPS | — | — | — | — | — | — | — | — | — |
CAGR applied: 18.81% (capped 20%) · P/E: 25.00x (capped 25x) · Margin: 15.60%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.